PATENT CLAIM ANALYSIS

Application Number: 16062245
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "204100"]

Abstract:
Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.

Claim (Index 24):
A Chikungunya virus vaccine comprising an attenuated Chikungunya virus particle grown on Vero cells, wherein the Chikungunya virus vaccine is able to confer seroprotection on at least 70% of subjects that are administered the Chikungunya virus vaccine and comprises minor amounts of protamine sulphate, preferably below the detection limit when measured with HPLC (below LOD) but still detectable by mass spectroscopy; i.e., trace amounts of PS and/or fragments thereof.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 94.0
- Lexical Diversity: 1.31034
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15781959', '16063007', '15212804', '15674585', '15674591']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7534341713059949
- 35 USC 102 Novelty (BERT): 0.6455747959626286
- Combined Prediction Score: 0.7426482337716583
- Mean Citation Score: 441.864336
- Max Citation Score: 668.9586
- Similarity Product: 571.1665011262537

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test